Clinical Trial Update: Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of LEO 152020 tablets in adults with moderate to severe atopic dermatitis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• LEO 152020

Snippet

Sponsor: JW Pharmaceutical | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2024-05-31